COMP <GO>
PLUS vs CLMB // EV/EBITDA & P/E VALUATION
ePlus inc. (NASDAQ) VS. Climb Global Solutions Inc. (NASDAQ) • 15-METRIC TALLY: PLUS 8
— CLMB 5
▲ EV/EBITDA & P/E VALUATION LEADER: PLUS
LAST: $95.49 (+0.35%) • MKT CAP: $2.49B
valuation
12.7x
LAST: $41.84 (+26.29%) • MKT CAP: $780.8M
valuation
25.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PLUS VS. CLMB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PLUS | CLMB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.20% | 16.10% | +9.10 | PLUS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.80% | 28.80% | -11.00 | CLMB | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 12.7x | 25.5x | -12.80 | PLUS | /valuation <GO> |
| Free Cash Flow Yield | -4.84% | 2.13% | -6.97 | CLMB | /fcf-yield <GO> |
| Operating Margin | 6.80% | 4.50% | +2.30 | PLUS | /operating-margins <GO> |
| Net Profit Margin | 5.40% | 3.30% | +2.10 | PLUS | /net-margins <GO> |
| Revenue Growth (YoY) | 22.10% | 40.10% | -18.00 | CLMB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.79% | 0.39% | +0.40 | PLUS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.81 | 3.35 | +1.46 | PLUS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | CLMB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.6 | 75.6 | -28.05 | CLMB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.8x | 30.7x | -14.90 | PLUS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.49B | $780.8M | $1.71B | PLUS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PLUS REV | CLMB REV | PLUS GROSS % | CLMB GROSS % | PLUS FCF | CLMB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.44B | $652.5M | 25.2% | 16.1% | -$120.7M | $16.6M |
| FY 2024 | $2.00B | $465.6M | 25.6% | 19.6% | $296.9M | $33.7M |
| FY 2023 | $2.18B | $352.0M | — | — | $248.4M | $42.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PLUS // BETA —
CLMB // BETA —